Starting July 1, 2026, eligible Medicare Part D enrollees can access Wegovy (semaglutide), Zepbound (tirzepatide, KwikPen formulation only), and Foundayo (orforglipron, an oral GLP-1 option) for a $50 monthly copay
Understanding GLP-1 Agonists GLP-1 agonists mimic natural hormones, regulating blood sugar and appetite, leading to reduced food intake and increased satiety
[DOI] [PubMed] [Google Scholar] Wu JQ, Kosten TR, Zhang XY
As a result, the individual will gain weight if they return to their regular eating habits
Buyers from such sites in Europe and elsewhere have been hospitalised for extremely low blood sugar, after injecting what they thought was a GLP-1 but turned out to be insulin, prompting global warnings for consumers to be wary
Avoid excessive alcohol and caffeine, as they can dehydrate you